Tubal Ligation: Weighing Risks and Options
The article explains tubal sterilization as a common US method with about 39 percent of reproductive age individuals relying on it. It outlines immediate postdelivery and interval tubals, mentions the FDA approved Essure device in 2002, and notes risks including rare procedure mortality and 1-3.5 percent surgical complications. It discusses regret risk from the CDC CREST study, especially higher for women under 30, and notes potential menstrual changes and higher hysterectomy rates after tubal sterilization. It urges careful option evaluation before permanent decisions.